Teva's Copaxone Trial Kicks Off Against Mylan, Sandoz
“They're different compositions, and they have different molecular ratios,” said Mylan attorney Shannon M. Bloodworth of Perkins Coie LLP in a standing-room-only courtroom in downtown Manhattan.
The remarks came during opening statements in a consolidated bench trial before U.S. District Judge Barbara S. Jones in two cases over Teva's allegations that Mylan and Novartis AG's...
Already a subscriber? Click here to login